Lovelace Biomedical Research Institute
Lovelace Biomedical Research Institute reported $83.4 million in revenue and $87.7 million in expenses for the fiscal year ending June 30, 2025. Of every $100 it spent, $87.85 went to program services, $12.15 to management and general costs and $0.00 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 75.6% of the total. Government grants made up 11.1%. The highest compensation it reported for one person was $1,387,128 (PRESIDENT AND CHAIRMAN OF THE BOARD). 43 people received more than $100,000 in reportable compensation. Revenue rose 9% between FY2020 and FY2025. Source: Form 990, FY2025.
Where $100 of spending went
The fiscal year ending June 30, 2025 · Form 990, Part IX, line 25 · total expenses $88MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
The fiscal year ending June 30, 2025 · Form 990, Part VIII · total revenue $83MThe 990 scorecard · same measures for every charity, no grades
| Measure | FY2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 87.9% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 12.1% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.00 | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 14.6% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 11.1% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 75.6% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $1,387,128 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 1.58% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 43 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 28.3 | 13.3 |
| Independent voting board members Part VI 1a–1b | 6 of 10 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
FY2025 · Form 990, Part III · the three largest programs by expenseMedical research and educational activity in the areas of basic Biomedical Research, health and population studies, including respiratory diseases such as asthma, copd, allergy and toxic effects of environmental factors. Additional areas include neurologic conditions such as traumatic brain injury, addiction and psychopathy
Highest reported compensation
FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| PRESIDENT AND CHAIRMAN OF THE BOARD Director/trustee, officer, 2.00 hrs/week | $0 | $1,265,315 | $121,813 | $1,387,128 |
| CEO (THROUGH 5/31/25) Officer, 38.00 hrs/week | $782,222 | $0 | $63,292 | $845,514 |
| EXEC VP, COO, CFO Officer, 40.00 hrs/week | $705,999 | $0 | $64,070 | $770,069 |
| CEO (STARTING 6/1/25) Officer, 38.00 hrs/week | $0 | $641,578 | $71,238 | $712,816 |
| VP, ACADEMIC RESEARCH/SR SCIENTIST Highest compensated employee, 40.00 hrs/week | $395,524 | $0 | $40,460 | $435,984 |
| SPECIAL APPOINTEE Director/trustee, 2.00 hrs/week | $0 | $355,397 | $71,226 | $426,623 |
| SPECIAL APPOINTEE Director/trustee, 2.00 hrs/week | $0 | $333,033 | $47,831 | $380,864 |
| EXECUTIVE SCIENCE OFFICER Highest compensated employee, 40.00 hrs/week | $334,368 | $0 | $41,570 | $375,938 |
43 people received more than $100,000 in reportable compensation from Lovelace Biomedical Research Institute (Part VII, line 2). Compensation of current officers, directors and key employees totaled $1.7M (Part IX, line 5).
6 filings since FY2020
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b10 · 6 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4Yes
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bNo
- Employees Part I, line 5495
- Volunteers Part I, line 66
Largest outside contractors
FY2025 · Form 990, Part VII, Section B · businesses only| BRADBURY STAMM CONSTRUCTION INC Construction services | $6,965,236 |
| SUMMIT CONSTRUCTION INC Construction services | $1,396,279 |
| NCA ARCHITECTS LLC Construction services | $1,228,877 |
| UNIVERSAL PROTECTION SERVICES LP Outsourced security services | $512,279 |
Individuals listed as contractors are left out. 5 contractors were paid more than $100,000 in all.
Correct a figure or respond
Every number above is copied from Lovelace Biomedical Research Institute's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Lovelace Biomedical Research Institute, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Lovelace Biomedical Research Institute spent in FY2025, $87.85 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Paralyzed Veterans of AmericaWashington, DC · revenue $83M · programs 58.9% · FY2025
- Parkinson's FoundationNew York, NY · revenue $84M · programs 85.5% · FY2025
- Benaroya Research Institute at VirginiaSeattle, WA · revenue $81M · programs 83.0% · FY2025
- The Morgridge Institute FoundationMadison, WI · revenue $85M · programs 90.8% · FY2025
- Licr FundNew York, NY · revenue $79M · programs 88.4% · 2024
All medical research charities · Largest charities in New Mexico
Questions people ask
How much of Lovelace Biomedical Research Institute's spending goes to programs?
In the fiscal year ending June 30, 2025, Lovelace Biomedical Research Institute reported that 87.9% of its $87.7 million in expenses went to program services, 12.1% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does Lovelace Biomedical Research Institute pay its top executive?
The largest total compensation Lovelace Biomedical Research Institute reported for one person in the fiscal year ending June 30, 2025 was $1,387,128, for the role of PRESIDENT AND CHAIRMAN OF THE BOARD (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Lovelace Biomedical Research Institute get its money?
Of $83.4 million in revenue in the fiscal year ending June 30, 2025, 14.6% came from contributions and grants (including 11.1% from government grants) and 75.6% from program service revenue (Form 990, Part VIII).
Is Lovelace Biomedical Research Institute a registered charity?
The IRS lists EIN 85-0110669 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- FY2025: Form 990 for the fiscal year ending June 30, 2025, object 202611349349304466 · read the filing · XML
- FY2024: Form 990 for the fiscal year ending June 30, 2024, object 202511329349301556 · read the filing
- FY2023: Form 990 for the fiscal year ending June 30, 2023, object 202400529349300525 · read the filing
- FY2022 (9 mo.): Form 990 for the 9-month short period ending June 30, 2022, object 202310839349300746 · read the filing
- FY2021: Form 990 for the fiscal year ending September 24, 2021, object 202211719349300141 · read the filing
- FY2020: Form 990 for the fiscal year ending September 25, 2020, object 202131069349300028 · read the filing
All filings for EIN 85-0110669: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.